Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Peroutka SJ |
Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine... |
N Engl J Med |
1987 |
Peroutka SJ, Pascoe N, Fa... |
Monoamine metabolites in the cerebralspinal fluid of recreational user... |
Research Comm in Sub... |
1987 |
O'Hearn E, Battaglia G, D... |
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... |
J Neurosci |
1988 |
Peroutka SJ, Newman H, Ha... |
Subjective effects of 3,4-methylenedioxymethamphetamine in recreationa... |
Neuropsychopharmacol... |
1988 |
Price LH, Ricaurte GA, Kr... |
Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-m... |
Arch Gen Psychiatry |
1989 |
Hashimoto K, Goromaru T |
Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-m... |
Neuropharmacology |
1990 |
McCann UD, Ricaurte GA |
Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine... |
J Clin Psychopharmac... |
1991 |
Kosten TR, Price LH |
Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use [C... |
Journal of Nervous &... |
1992 |
Krystal JH, Price LH, Ops... |
Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood ... |
Am J Drug Alcohol Ab... |
1992 |
Liester MB, Grob CS, Brav... |
Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use |
J Nerv Ment Dis |
1992 |
Lim HK, Zeng S, Foltz RL |
Comparative investigation of disposition of 3,4-(methylenedioxy)metham... |
J Pharm Biomed Anal |
1992 |
Hooft PJ, van de Voorde H... |
Reckless behaviour related to the use of 3,4-methylenedioxymethampheta... |
Int J Legal Med |
1994 |
McGuire PK, Cope H, Fahy ... |
Diversity of psychopathology associated with use of 3,4-methylenedioxy... |
Br J Psychiatry |
1994 |
Hanyu S, Ikeguchi K, Imai... |
Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ... |
Eur Neurol |
1995 |
Cohen RS |
Adverse symptomatology and suicide associated with the use of methylen... |
Biol Psychiatry |
1996 |
Crifasi J, Long C |
Traffic fatality related to the use of methylenedioxymethamphetamine |
J Forensic Sci |
1996 |
Nakahara Y, Kikura R |
Hair analysis for drugs of abuse. XVIII. 3,4-Methylenedioxymethampheta... |
Biol Pharm Bull |
1997 |
Cohen RS, Cocores J |
Neuropsychiatric manifestations following the use of 3,4-methylenediox... |
Prog Neuropsychophar... |
1997 |
Kikura R, Nakahara Y, Mie... |
Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxyme... |
Forensic Sci Int |
1997 |
Huether G, Zhou D, Ruther... |
Causes and consequences of the loss of serotonergic presynapses elicit... |
J Neural Transm |
1997 |
Malberg JE, Seiden LS |
Small changes in ambient temperature cause large changes in 3,4-methyl... |
J Neurosci |
1998 |
Redfearn PJ, Agrawal N, M... |
An association between the regular use of 3,4 methylenedioxy-methamphe... |
Addiction |
1998 |
Nakahara Y, Kikura R, Tak... |
Hair analysis for drugs of abuse XX. Incorporation and behaviors of se... |
Life Sci |
1998 |
Milosevic A, Agrawal N, R... |
The occurrence of toothwear in users of Ecstasy (3,4-methylenedioxymet... |
Community Dent Oral ... |
1999 |
Chang L, Ernst T, Grob CS... |
Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymetha... |
J Magn Reson Imaging |
1999 |
McCann UD, Mertl M, Eligu... |
Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA... |
Psychopharmacology (... |
1999 |
Dafters RI, Duffy F, O'Do... |
Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in... |
Psychopharmacology (... |
1999 |
McCann UD, Eligulashvili ... |
Altered neuroendocrine and behavioral responses to m-chlorophenylpiper... |
Psychopharmacology (... |
1999 |
Erdtmann-Vourliotis M, Ma... |
Acute injection of drugs with low addictive potential (delta(9)-tetrah... |
Brain Res Mol Brain ... |
1999 |
Jayanthi S, Ladenheim B, ... |
Overexpression of human copper/zinc superoxide dismutase in transgenic... |
Neuroscience |
1999 |
Gorman EM, Carroll RT |
Substance abuse and HIV: considerations with regard to methamphetamine... |
J Assoc Nurses AIDS ... |
2000 |
Nakahara Y, Hanajiri R |
Hair analysis for drugs of abuse XXI. Effect of para-substituents on b... |
Life Sci |
2000 |
Rothman RB, Partilla JS, ... |
Neurochemical neutralization of methamphetamine with high-affinity non... |
Synapse |
2000 |
Zenenberg R, Goldfarb DS |
Evaluation of hyponatremia associated with the use of methylenedioxyme... |
Int J Med Toxicol |
2000 |
Bhattachary S, Powell JH |
Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecsta... |
Psychol Med |
2001 |
Carvalho M, Carvalho F, B... |
Is hyperthermia the triggering factor for the hepatoxicity induced by ... |
Arch Toxicol |
2001 |
MacInnes, N, Handley, SL ... |
Former chronic methylenedioxymethamphetamine (mdma or ecstasy) users r... |
J Psychopharmacology |
2001 |
Navarro M, Pichini S, Far... |
Usefulness of saliva for measurement of 3,4- methylenedioxymethampheta... |
Clinical Chemistry |
2001 |
Gerra G, Zaimovic A, Ampo... |
Experimentally induced aggressive behavior in subjects with 3,4- methy... |
Journal of Substance... |
2001 |
Ho E, Karimi-Tabesh L, Ko... |
Characteristics of pregnant women who use Ecstasy (3, 4- methylenediox... |
Neurotoxicol Teratol |
2001 |
Colado MI, Camarero J, Me... |
A study of the mechanisms involved in the neurotoxic action of 3,4- me... |
Br J Pharmacol |
2001 |
Reneman L, Majoie CB, Fli... |
Reduced N-acetylaspartate levels in the frontal cortex of 3,4- methyle... |
AJNR Am J Neuroradio... |
2002 |
Pichini S, Navarro M, Far... |
On-site testing of 3,4-methylenedioxymethamphetamine (ecstasy) in sali... |
Clin Chem |
2002 |
Gesi M, Lenzi P, Soldani ... |
Morphological effects in the mouse myocardium after methylenedioxymeth... |
Anat Rec |
2002 |
Camarero J, Sanchez V, O'... |
Studies, using in vivo microdialysis, on the effect of the dopamine up... |
J Neurochem |
2002 |
Zakzanis KK, Young DA, Ra... |
Attentional processes in abstinent methylenedioxymethamphetamine (ecst... |
Appl Neuropsychol |
2002 |
Brecht ML, von Mayrhauser... |
Differences between ecstasy-using and non-using methamphetamine users |
J Psychoactive Drugs |
2002 |
Fantegrossi WE, Godlewski... |
Pharmacological characterization of the effects of 3,4-methylenedioxym... |
Psychopharmacology (... |
2003 |
Zhou JF, Zhou YH, Zhang L... |
3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acety... |
Biomed Environ Sci |
2003 |
Zhou JF, Chen P, Zhou YH,... |
3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative str... |
Free Radic Res |
2003 |
Gerra G, Bassignana S, Za... |
Hypothalamic-pituitary-adrenal axis responses to stress in subjects wi... |
Psychiatry Res |
2003 |
Back-Madruga C, Boone KB,... |
Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA ... |
Clin Neuropsychol |
2003 |
London ED, Simon SL, Berm... |
Mood disturbances and regional cerebral metabolic abnormalities in rec... |
Arch Gen Psychiatry |
2004 |
Wang GJ, Volkow ND, Chang... |
Partial recovery of brain metabolism in methamphetamine abusers after ... |
Am J Psychiatry |
2004 |
Falck RS, Carlson RG, Wan... |
Sources of information about MDMA (3,4-methylenedioxymethamphetamine):... |
Drug and Alcohol Dep... |
2004 |
Thompson PM, Hayashi KM, ... |
Structural abnormalities in the brains of human subjects who use metha... |
J Neurosci |
2004 |
Baumann MH, Clark RD, Bud... |
N-substituted piperazines abused by humans mimic the molecular mechani... |
Neuropsychopharmacol... |
2005 |
Segura M, Farre M, Pichin... |
Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetami... |
Clin Pharmacokinet |
2005 |
McCann UD, Szabo Z, Vrane... |
Positron emission tomographic studies of brain dopamine and serotonin ... |
Psychopharmacology (... |
2008 |
Galloway GP, Singleton EG... |
How long does craving predict use of methamphetamine? Assessment of us... |
Subst Abuse |
2009 |
Galloway GP, Singleton EG... |
An examination of drug craving over time in abstinent methamphetamine ... |
Am J Addict |
2010 |
Hart CL, Marvin CB, Silve... |
Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical... |
Neuropsychopharmacol... |
2011 |
Angoa-Pérez M, Kane MJ, F... |
Mephedrone, an abused psychoactive component of 'bath salts' and metha... |
J Neurochem |
2012 |